Julio Torres-Navedo, M.D.

8.6 times the Medicare Part D claims of the average otolaryngology physician in 2024

4,611 Medicare Part D claims for 759 beneficiaries, against an average of 536 among the 7,899 providers of this specialty who prescribed in Part D. Brand-name drugs were 1% of claims. 19 claims were for opioids.

Most prescribed

1. Fluticasone Propionate992 claims
2. Azelastine Hcl834 claims
3. Levocetirizine Dihydrochloride670 claims
4. Ipratropium Bromide287 claims
5. Famotidine183 claims
6. Montelukast Sodium148 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's Medicare quality score for 2023: 87.6 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

One hospital or facility affiliation

1. Florida Ent Associates IncHialeah, FL

Source: CMS Doctors and Clinicians affiliations; Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.